UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Kidney international, ISSN 0085-2538, 10/2015, Volume 88, Issue 4, pp. 676 - 683
kidney disease | uromodulin | hepatocyte nuclear factor-1β | genetics | mucin-1 | renin | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Predictive Value of Tests | Humans | Kidney Diseases - diagnosis | Polycystic Kidney, Autosomal Dominant - therapy | Gout - diagnosis | Nephrology - standards | Kidney Diseases - genetics | Uromodulin - classification | Uromodulin - deficiency | Polycystic Kidney, Autosomal Dominant - genetics | DNA Mutational Analysis | Hyperuricemia - therapy | Uromodulin - genetics | Genetic Predisposition to Disease | Kidney Diseases - classification | Hyperuricemia - diagnosis | Hyperuricemia - classification | Terminology as Topic | Treatment Outcome | Consensus | Hyperuricemia - genetics | Gout - therapy | Phenotype | Polycystic Kidney, Autosomal Dominant - diagnosis | Kidney Diseases - therapy | Gout - classification | Gout - genetics | Polycystic Kidney, Autosomal Dominant - classification | Mutation | Index Medicus
Journal Article
Kidney international, ISSN 0085-2538, 07/2015, Volume 88, Issue 1, pp. 17 - 27
diagnosis | ADPKD | patient support | end-stage renal disease | management | polycystic kidney disease | FOLLOW-UP | INDIVIDUAL PATIENT DATA | LIVER-DISEASE | PREIMPLANTATION GENETIC DIAGNOSIS | UNRUPTURED INTRACRANIAL ANEURYSMS | CYST INFECTION | LONG-ACTING SOMATOSTATIN | LEFT-VENTRICULAR MASS | QUALITY-OF-LIFE | RENAL REPLACEMENT THERAPY | End-stage renal disease | Diagnosis | Management | Patient support | Polycystic kidney disease | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2019, Volume 393, Issue 10174, pp. 919 - 935
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Genetic Testing | Humans | Middle Aged | Polycystic Kidney, Autosomal Dominant - therapy | Male | Disease Progression | Cysts - complications | Randomized Controlled Trials as Topic | Magnetic Resonance Imaging | Polycystic Kidney, Autosomal Dominant - diagnosis | Ultrasonography | Liver Diseases - complications | Adult | Female | Aged | Polycystic Kidney, Autosomal Dominant - physiopathology | Mutation | Polycystic Kidney, Autosomal Dominant - complications | Hypertension | Medical colleges | Medical research | Chronic kidney failure | Molecular genetics | Liver | Medicine, Experimental | Aneurysms | Development and progression | Health aspects | Polycystic kidney disease | End-stage renal disease | Genomics | Genes | Clinical trials | Information systems | Proteins | Ultrasonic imaging | Genetics | Heart diseases | Enzymes | Kidneys | Liver diseases | Complications | Polycystic kidney | Health risks | Imaging techniques | Disease control | Patients | Coronary artery disease | Nutrition research | Cysts | Renal failure | Kidney diseases | Cardiovascular diseases | Endoplasmic reticulum | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9903, pp. 1485 - 1495
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | General aspects | Kidneys | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Malformations of the urinary system | Somatostatin - analogs & derivatives | Kidney - drug effects | Follow-Up Studies | Kidney - pathology | Cholecystitis, Acute - chemically induced | Humans | Middle Aged | Polycystic Kidney, Autosomal Dominant - pathology | Octreotide - adverse effects | Male | Treatment Outcome | Octreotide - therapeutic use | Disease Progression | Magnetic Resonance Imaging | Organ Size - drug effects | Kidney Failure, Chronic - prevention & control | Gastrointestinal Agents - therapeutic use | Adult | Female | Italy | Gastrointestinal Agents - adverse effects | Cholelithiasis - chemically induced | Polycystic Kidney, Autosomal Dominant - drug therapy | Care and treatment | Octreotide acetate | Health aspects | Polycystic kidney disease | Proteins | Studies | Cell growth | Liver diseases | Cysts | Rodents | Kidney diseases | Urogenital system | Blood | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 25, pp. 2407 - 2418
VOLUME PROGRESSION | VASOPRESSIN V-2-RECEPTOR ANTAGONIST | ORAL TOLVAPTAN | HYPONATREMIA | RENAL-FUNCTION | OPC-41061 | LONG-ACTING SOMATOSTATIN | V2 RECEPTOR ANTAGONIST | UMCG Approved | CYST GROWTH | SIROLIMUS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Nephrology. Urinary tract diseases | Biological and medical sciences | General aspects | Kidneys | Medical sciences | Malformations of the urinary system | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Polycystic kidney disease | Studies | Nuclear magnetic resonance--NMR | Kidney diseases | Cysts | Rodents | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9569, pp. 1287 - 1301
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Nephrology. Urinary tract diseases | Biological and medical sciences | General aspects | Kidneys | Medical sciences | Malformations of the urinary system | Cardiovascular Diseases - etiology | Humans | Kidney Tubules - physiology | Renal Replacement Therapy | Genotype | Male | Incidence | Kidney Failure, Chronic - therapy | Kidney Tubules - anatomy & histology | Animals | Kidney Failure, Chronic - epidemiology | Polycystic Kidney, Autosomal Dominant - genetics | Pain - etiology | Female | Polycystic Kidney, Autosomal Dominant - physiopathology | Kidney Tubules - metabolism | Polycystic Kidney, Autosomal Dominant - complications | Genetic aspects | Risk factors | Polycystic kidney disease | Medical research | Parents & parenting | Disease | Cysts | Rodents | African Americans | Kidney diseases | Mutation | Cells | Congenital diseases | Liver diseases | Polycystic kidney | Intellectual disabilities | Clinical trials | Kinases | Molecular chains | Proteins | Hernias | Localization | Endoplasmic reticulum | Age | Index Medicus | Abridged Index Medicus
Journal Article